CD44 in human placenta: localization and binding to hyaluronic acid.
CD44, a receptor for hyaluronic acid (HA), has been identified in the stroma of stem and terminal chorionic villi of human term placenta. The CD44 glycoprotein antigen, isolated from placenta by affinity to monoclonal antibody (mAb) 50B4, consisted mainly of species of M(r) 85,000 and 200,000. Radiolabelled CD44 bound specifically to HA attached to plastic, predominantly via the M(r) 85,000 species; this binding was inhibited by soluble HA and hyaluronidase. The binding of CD44 to HA was also inhibited by mAb 50B4 and IM7.8.1, which recognize epitopes of cluster I and II respectively, but was not blocked by a polyclonal antibody to peptide 18-30 of the B loop (residues 12-101). These results suggest that the portion of the B loop of CD44 implicated in the binding to HA is between amino acids 31-101 and that epitopes located outside the B loop, such as that recognized by mAb IM7.8.1 (between residues 132-215), contribute to this interaction. The presence of a functional CD44 molecule in the human term placenta suggest a role for this molecule in situ in the stabilization and orientation of HA network important in the maintenance of the structural integrity of the placenta.
St Jacques
S
S
Division of Immunology and Cancer Research, Hospital For Sick Children, Toronto, Canada.
Dadi
H K
HK
Letarte
M
M
D000906:Antibodies / Q000276:immunology; D005260:Female; D006801:Humans; D006820:Hyaluronic Acid / Q000378:metabolism*; D010920:Placenta / Q000276:immunology*; D011247:Pregnancy; D016201:Receptors, Lymphocyte Homing / Q000032:analysis* / Q000302:isolation & purification / Q000378:metabolism
D000906:Antibodies; D016201:Receptors, Lymphocyte Homing; D006820:Hyaluronic Acid